Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification

被引:10
作者
Yamamoto, Masateru [1 ,2 ]
Kobayashi, Tsuyoshi [1 ,2 ]
Hashimoto, Masakazu [1 ,2 ]
Kuroda, Shintaro [1 ,2 ]
Kawaoka, Tomokazu [2 ,3 ]
Aikata, Hiroshi [2 ,3 ]
Chayama, Kazuaki [2 ,3 ]
Ohdan, Hideki [1 ,2 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Res Ctr Hepatol & Gastroenterol, Hiroshima, Japan
[3] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan
关键词
BCLC staging system; Hepatocellular carcinoma; Intermediate stage; Kinki criteria; Liver resection; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC RESECTION; CANCER; HETEROGENEITY; SORAFENIB; SYSTEM;
D O I
10.1186/s12885-021-08421-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPatients diagnosed with Barcelona Clinic Liver Cancer (BCLC) intermediate stage hepatocellular carcinoma (HCC) encompass a broad clinical population. Kinki criteria subclassifications have been proposed to better predict prognoses and determine appropriate treatment strategies for these patients. This study validated the prognostic significance within the Kinki criteria substages and analyzed the role of liver resection in patients with intermediate stage HCC.MethodsPatients with intermediate stage HCC (n=378) were retrospectively subclassified according to the Kinki criteria (B1, n=123; B2, n=225; and B3, n=30). We analyzed the overall survival (OS) and treatment methods.ResultsThe OS was significantly different between adjacent substages. Patients in substage B1 who underwent liver resection had a significantly better prognosis than those who did not, even after propensity score matching (PSM). Patients in substage B2 who underwent liver resection had a significantly better prognosis than those who did not; however, there was no difference after PSM. There was no difference in prognosis based on treatments among patients in substage B3.ConclusionsThe Kinki criteria clearly stratify patients with intermediate stage HCC by prognosis. For substage B1 HCC patients, liver resection provides a better prognosis than other treatment modalities. In patients with substage B2 and B3, an alternative approach is required.
引用
收藏
页数:11
相关论文
共 31 条
  • [1] Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
    Bolondi, Luigi
    Burroughs, Andrew
    Dufour, Jean-Francois
    Galle, Peter R.
    Mazzaferro, Vincenzo
    Piscaglia, Fabio
    Raoul, Jean Luc
    Sangro, Bruno
    [J]. SEMINARS IN LIVER DISEASE, 2012, 32 (04) : 348 - 359
  • [2] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [3] A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
    Feng, Kai
    Yan, Jun
    Li, Xiaowu
    Xia, Feng
    Ma, Kuansheng
    Wang, Shuguang
    Bie, Ping
    Dong, Jiahong
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 794 - 802
  • [4] Hepatocellular carcinoma
    Forner, Alejandro
    Reig, Maria
    Bruix, Jordi
    [J]. LANCET, 2018, 391 (10127) : 1301 - 1314
  • [5] Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
    Hyun, Myung Han
    Lee, Young-Sun
    Kim, Ji Hoon
    Lee, Chan Uk
    Jung, Young Kul
    Seo, Yeon Seok
    Yim, Hyung Joon
    Yeon, Jong Eun
    Byun, Kwan Soo
    [J]. HEPATOLOGY, 2018, 68 (03) : 977 - 993
  • [6] Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
    Ishizawa, Takeaki
    Hasegawa, Kiyoshi
    Aoki, Taku
    Takahashi, Michiro
    Inoue, Yosuke
    Sano, Keiji
    Imamura, Hiroshi
    Sugawara, Yasuhiko
    Kokudo, Norihiro
    Makuuchi, Masatoshi
    [J]. GASTROENTEROLOGY, 2008, 134 (07) : 1908 - 1916
  • [7] Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinoma
    Kawaoka, Tomokazu
    Aikata, Hiroshi
    Kobayashi, Tomoki
    Uchikawa, Shinsuke
    Ohya, Kazuki
    Kodama, Kenichiro
    Nishida, Yuno
    Daijo, Kana
    Osawa, Mitsutaka
    Teraoka, Yuji
    Inagaki, Yuki
    Honda, Fumi
    Hatooka, Masahiro
    Morio, Kei
    Morio, Reona
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Baba, Yasutaka
    Awai, Kazuo
    Chayama, Kazuaki
    [J]. HEPATOLOGY RESEARCH, 2018, 48 (13) : 1118 - 1130
  • [8] Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma
    Kawaoka, Tomokazu
    Aikata, Hiroshi
    Hyogo, Hideyuki
    Morio, Reona
    Morio, Kei
    Hatooka, Masahiro
    Fukuhara, Takayuki
    Kobayashi, Tomoki
    Naeshiro, Noriaki
    Miyaki, Daisuke
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Takahashi, Shoichi
    Waki, Koji
    Tsuji, Keiji
    Kohno, Hirotaka
    Kohno, Hiroshi
    Moriya, Takashi
    Chayama, Kazuaki
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2015, 16 (09) : 505 - 512
  • [9] Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies
    Kimura, Tomoki
    Aikata, Hiroshi
    Doi, Yoshiko
    Imano, Nobuki
    Takeuchi, Yuki
    Takahashi, Ippei
    Nishibuchi, Ikuno
    Katsuta, Tsuyoshi
    Kenjo, Masahiro
    Murakami, Yuji
    Kenjo, Masahiro
    Murakami, Yuji
    Awai, Kazuo
    Chayama, Kazuaki
    Nagata, Yasushi
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [10] Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JS']JSH-HCC guidelines) 2019 update
    Kokudo, Norihiro
    Takemura, Nobuyuki
    Hasegawa, Kiyoshi
    Takayama, Tadatoshi
    Kubo, Shoji
    Shimada, Mitsuo
    Nagano, Hiroaki
    Hatano, Etsuro
    Izumi, Namiki
    Kaneko, Shuichi
    Kudo, Masatoshi
    Iijima, Hiroko
    Genda, Takuya
    Tateishi, Ryosuke
    Torimura, Takuji
    Igaki, Hiroshi
    Kobayashi, Satoshi
    Sakurai, Hideyuki
    Murakami, Takamichi
    Watadani, Takeyuki
    Matsuyama, Yutaka
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (10) : 1109 - 1113